Panelists:

• Mark Morgan, MBA
  Mark Morgan is a senior healthcare executive with more than 30 years of experience in diagnostics, payer strategy, and market access. He previously served as President of Anthem Blue Cross in California and as Senior Vice President for Network Management at Blue Shield of California, where he led major initiatives in provider relations and reimbursement strategy. In the biotechnology sector, he held senior leadership roles at Amgen, UCB, and GRAIL, driving the integration of innovative diagnostic technologies into health systems and payer frameworks. Mr. Morgan now advises diagnostics companies on commercialization, partnerships, and reimbursement strategy, including his current advisory role with Novelna.

• Susan J. Gross, MD
  Dr. Susan J. Gross is the Chief Executive Officer of HcFocus LLC, where she leads regulatory strategy, payer engagement, and clinical affairs consulting for diagnostics and digital health organizations. A physician-scientist and accomplished industry executive, she previously served as the founding Chief Medical Officer of Natera and as a professor of obstetrics, gynecology, pediatrics, and genetics at Albert Einstein College of Medicine. Drawing on her combined clinical, academic, and industry experience, Dr. Gross guides diagnostic innovators in aligning regulatory compliance, evidence generation, and reimbursement pathways to accelerate market access.

• Patrick Grogan, MBA
  Patrick Grogan serves as the Vice President of Commercialization at Novelna, where he leads the company’s commercialization strategy, pricing model development, and partnership execution for its proteomics-based diagnostic portfolio. With extensive experience in bringing advanced diagnostic technologies to market, Mr. Grogan previously served as Senior Vice President of Commercial Development at InSilixa, where he oversaw the go-to-market strategy for molecular testing platforms. He specializes in building commercialization frameworks that align clinical validation, payer readiness, and strategic partnerships to drive sustainable market adoption.